Patent
The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis. 1 ATGAAAAAGA CATTAACTTT GCTACTGGCA CTCTTTGCCA TCGGGGTAAC TAGTAGCGTC 61 AGAGCG GAGG ATGAACAAAG TAGTACACAA AAGCCAGTAA AATTTGATTT GGATGGACCT 121 CAACAAAAAA TTAAAGATTA TAGTGGCAAC ACAATCACTC TAGAAGACTT ATATGTTGGT 181 AGTAAAGTAG TAAAAATATA TATCCCTCAA GGATGGTGGG TATATCTTTA CAGACAATGT 241 GATCATAACA GTAAAGAACG AGGAATTTTA GCTAGTCCTA TTCTCGAAAA AAATATAACA 301 AAAACAGATC CTTATCGTCA ATATTATACA GGAGTACCTT ATATTCTTAA CTTAGGAGAA 361 GATCCTTTGA AGAAAGGAGA AAAATTAACT TTCTCATTTA AAGGAGAAGA CGGATTTTAT 421 GTCGGTAGCT ATATCTATAG AGACTCTGAT ACTATAAAAA AAGAAAAAGA AGCTGAAGAA 481 GCACTTCAAA AAAAGGAAGA GGAAAAGCAA CAAAAACAGC TAGAAGAAAG CATGCTAAAG 541 CAGATAAGAG AAGAAGACCA TAAACCTTGG CATCAGCGGT TAAGTGAGAG CATCCAAGAT 601 CAGTGGTGGA ACTTTAAGGG AQTGTTTCAG TGA
1. An isolated polypeptide comprising an amino acid sequence that is at least 90% identical to the full-length amino acid sequence set forth in SEQ ID NO: 10, wherein the isolated polypeptide is capable of inducing an immune response to Streptococcus pyogenes , and wherein the isolated polypeptide is capable of generating an antibody that specifically binds to a protein consisting of the amino acid sequence set forth in SEQ ID NO: 10.
2. The isolated polypeptide according to claim 1 wherein the polypeptide comprises an amino acid sequence at least 95% identical to the amino acid sequence set forth in SEQ ID NO: 10.
3. The isolated polypeptide according to claim 1 wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 10.
4. The isolated polypeptide according to claim 3 from which the N-terminal methionine residue of SEQ ID NO: 10 is deleted.
5. An isolated polypeptide comprising an amino acid sequence that is at least 95% identical to the full-length amino acid sequence set forth in SLO ID NO: 10 from which the signal peptide amino acid sequence is deleted, wherein the signal peptide amino acid sequence is set forth in SEQ ID NO: 47.
6. A pharmaceutical composition comprising the isolated polypeptide according to any one of claims 1 - 5 and a pharmaceutically acceptable carrier or diluent.
7. The pharmaceutical composition according to claim 6 further comprising an adjuvant.
8. A kit comprising a polypeptide according to any one of claims 1 - 5 for detection or diagnosis of a streptococcal infection.
9. The kit according to claim 8 wherein the streptococcal infection is a Streptococcus pyogenes infection.
10. A method for therapeutic treatment of Streptococcus pyogenes bacterial infection in a host susceptible to Streptococcus pyogenes infection comprising administering to said host a therapeutic amount of a composition comprising the isolated polypeptide according to claim 1 and a pharmaceutically diluent or carrier.
11. The method according to claim 10 wherein the composition further comprises an adjuvant.
12. A method according to claim 10 wherein the host is a human or non-human animal.